Adeghate, E, Ponery, AS, Sharma, AK, El Sharkawy, T & Donáth, T 2001, Diabetes mellitus is associated with a decrease in vasoactive intestinal polypeptide content of gastrointestinal tract of rat. Archives of Physiology and Biochemistry, 109: 246-251.
Adeva Andany, MM, Funcasta Calderón, R, Fernández Fernández, C, Castro Quintela, E & Carneiro Freire, N 2019, Metabolic effects of glucagon in humans. Journal of Clinical and Translational Endocrinology, 15: 45-53.
Afsartala, Z, Savabkar, S, Mojarad, EN, Assadollahi, V, Tanha, S, Bijangi, K & Gholami, M 2016, Expression of liver alpha-amylase in obese mouse hepatocytes. Gastroenterology and Hepatology From Bed to Bench, 9: 278.
Al Goblan, AS, Al Alfi, MA & Khan, MZ 2014, Mechanism linking diabetes mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7: 587.
Atas, U, Erin, N, Tazegul, G, Elpek, GO & Yildirim, B 2021, Changes in ghrelin, substance P and vasoactive intestinal peptide levels in the gastroduodenal mucosa of patients with morbid obesity. Neuropeptides, 102164.
Badin, PM, Louche, K, Mairal, A, Liebisch, G, Schmitz, G, Rustan, AC & Moro, C 2011, Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes, 60: 1734-1742.
Baranowska, B 1991, A marked decrease of vasoactive intestinal peptide release in obese patients. Metabolism, 40: 344-346.
Barnett, CA & Whitney, JE 1965, Effects of Trypsin and Chymotrypsin on Blood Glucose in vivo and Glucose Uptake in vitro. Proceedings of the Society for Experimental Biology and Medicine, 119: 866-869.
Blüher, M 2016, Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?, Clinical Science, 130: 1603-1614.
Boden, G 2008, Obesity and free fatty acids. Endocrinology and Metabolism Clinics of North America, 37: 635-646.
Boehm, BO 2003, The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes. Expert Opinion on Investigational Drugs, 12: 1501-1509.
Cao, SG, Wu, WC, Han, Z & Wang, MY 2005, Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice. World Journal of Gastroenterology, 11: 737.
Casoinic, F, Sampelean, D, Buzoianu, AD, Hancu, N & Baston, D 2016, Serum levels of oxidative stress markers in patients with type 2 diabetes mellitus and non-alcoholic steatohepatitis. Romanian Journal of Internal Medicine, 54: 228-236.
De Boer, MP, Meijer, RI, Wijnstok, NJ, Jonk, AM, Houben, AJ, Stehouwer, CD & Serne, EH 2012, Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity‐associated insulin resistance and hypertension. Microcirculation, 19: 5-18.
Del Prato, S, Gallwitz, B, Holst, JJ & Meier, JJ 2021, The incretin/glucagon system as a target for pharmacotherapy of obesity. Obesity Reviews.
Diéguez Castillo, C, Jiménez Luna, C, Martín Ruiz, JL, Martínez Galán, J, Prados, J, Torres, C & Caba, O 2020, Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis. Journal of Clinical Medicine, 9: 2014.
Duan, RD, Poensgen, J, Wicker, C, Weström, B & Erlanson Albertsson, C 1989, Increase in pancreatic lipase and trypsin activity and their mRNA levels in streptozotocin-induced diabetic rats. Digestive Diseases and Sciences, 34: 1243-1248.
Dybala, MP, Kuznetsov, A, Motobu, M, Hendren Santiago, BK, Philipson, LH, Chervonsky, AV & Hara, M 2020, Integrated pancreatic blood flow: bidirectional microcirculation between endocrine and exocrine pancreas. Diabetes, 69: 1439-1450.
Eibl, G 2020, Endocrine–exocrine signals in obesity-associated pancreatic cancer. Nature Reviews, Gastroenterology and Hepatology, 17: 455-456.
Ershow, AG 2009, Environmental influences on development of type 2 diabetes and obesity: challenges in personalizing prevention and management. Journal of Diabetes Science and Technology, 3: 727-734.
Feingold, KR 2020, Obesity and dyslipidemia. Endotext [Internet].
Femlak, M, Gluba Brzozka, A, Franczyk, B & Rysz, J 2020, Diabetes-induced alterations in HDL sub-fractions distribution. Current Pharmaceutical Design, 26: 3341-3348.
Fex, M, Lucas, S, Winzell, MS, Ahrén, B, Holm, C & Mulder, H 2006, β-Cell lipases and insulin secretion. Diabetes, 55 (Supplement 2): S24-S31.
Firdous, S 2014, Correlation of CRP, fasting serum triglycerides and obesity as cardiovascular risk factors. Journal of College of Physicians and Surgeons Pakistan, 24: 308-313.
Flegal, KM, Carroll, MD, Ogden, CL & Curtin, LR 2010, Prevalence and trends in obesity among US adults, 1999-2008. Jama, 303: 235-241.
Foghsgaard, S, Andreasen, C, Vedtofte, L, Andersen, ES, Bahne, E, Strandberg, C & Vilsbøll, T 2017, Nonalcoholic fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference. Diabetes Care, 40: 109-116.
Frantz, EDC, de Souza Mello, V & Mandarim de Lacerda, CA 2012, Pancreas: anatomy, diseases and health implications. Pancreatic Cancer, Nova Science Publishers Inc., New York, p: 1-52.
Freeman, SC, Malik, A & Basit, H 2019, Physiology, Exocrine Gland. StatPearls Publishing, Treasure Island (FL), USA, p: 1-5.
Frier, BM, Adrian, TE, Saunders, JHB & Bloom, SR 1980, Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus. Clinica Chimica Acta, 105: 297-300.
Fuglsang Nielsen, R, Rakvaag, E, Vestergaard, P, Hartmann, B, Holst, JJ, Hermansen, K & StarupLinde, J 2020, Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity. Bone, 133, 115230.
Furman, BL 2021, Streptozotocin‐Induced Diabetic Models in Mice and Rats. Current Protocols, 1: 78.
Ganea, D, Hooper, KM & Kong, W 2015, The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiologica, 213: 442-452.
Ganeva, SS, Rayanova, GH, Todorova, KN, Lukanov, TH & Blazheva, SO 2021, The Role of Triglyceride to HDL Cholesterol Ratio in Sera as a Clinical Surrogate Marker for Cardiovascular Risk and Insulin Resistance in Patients with Metabolic Syndrome. Journal of Biomedical and Clinical Research, 14: 1-7.
Gerich, JE 2019, Regulation of somatostatin secretion and its biologic actions. In Hormones in normal and abnormal human tissues, De Gruyter, 2: 475-518.
Godoy Matos, AF 2014, The role of glucagon on type 2 diabetes at a glance. Diabetology and Metabolic Syndrome, 6: 1-5.
Goldberg, IJ, Hu, Y, Noh, HL, Wei, J, Huggins, LA, Rackmill, MG & Huang, LS 2008, Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes, 57: 1674-1682.
Gomes Porras, M & Cárdenas Salas, J 2020, Somatostatin analogues in clinical practice: a review. International Journal of Molecular Sciences, 21: 1682.
Hædersdal, S, Lund, A, Knop, FK & Vilsbøll, T 2018, The role of glucagon in the pathophysiology and treatment of type 2 diabetes. In: Mayo Clinic Proceedings, 93: 217-239, Elsevier.
Haththotuwa, RN, Wijeyaratne, CN & Senarath, U 2020, Worldwide epidemic of obesity. In Obesity and Obstetrics, pp: 3-8. Elsevier.
Haymond, MW, Liu, J, Bispham, J, Hickey, A & McAuliffe Fogarty, AH 2019, Use of glucagon in patients with type 1 diabetes. Clinical Diabetes, 37: 162-166.
Henquin, JC, Ibrahim, MM & Rahier, J 2017, Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls. Scientific Reports, 7: 1-9.
Hogenboom, R, Kalsbeek, MJ, Korpel, NL, de Goede, P, Koenen, M, Buijs, RM & Yi, CX 2019, Loss of arginine vasopressin-and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes. Diabetologia, 62: 2088-2093.
Iwasaki, M, Akiba, Y & Kaunitz, JD 2019, Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the Gastrointestinal System. F1000 Research, 8.
Jaworski, K, Sarkadi Nagy, E, Duncan, RE, Ahmadian, M & Sul, HS 2007, Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. American Journal of Physiology-Gastrointestinal and Liver Physiology, 293: G1-G4.
Jayawardena, D, Guzman, G, Gill, RK, Alrefai, WA, Onyuksel, H & Dudeja, PK 2017, Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology, 313: G16-G25.
Kaba, S, Doğan, M, Bala, KA, Karaman, K, and Kocaman, S 2015, The Relationship of Gastrin Levels with Obesity Anthropometrics, Lipid, Glucose, and Insulin Levels in Children and Adolescents with Obesity. Journal of Paediatric Biochemistry, 5: 098-102.
Kim, HG & Han, J 2012, Obesity and pancreatic diseases. The Korean Journal of Gastroenterology, 59: 35-39.
Kim, SM, Lim, SM, Yoo, JA, Woo, MJ & Cho, KH 2015, Consumption of high-dose vitamin C (1250 mg per day) enhances functional and structural properties of serum lipoprotein to improve anti-oxidant, anti-atherosclerotic, and anti-aging effects via regulation of anti-inflammatory microRNA. Food and Function, 6: 3604-3612.
Klop, B, Elte, JWF & Cabezas, MC 2013, Dyslipidemia in obesity: mechanisms and potential targets. Nutrients, 5: 1218-1240.
Ko, J, Cho, J & Petrov, MS 2020, Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: a systematic review and meta-analysis. Diabetes Research and Clinical Practice, 159: 107974.
Kondo, T, Hayakawa, T, Shibata, T, Sato, Y & Toda, Y 1988, Serum levels of pancreatic enzymes in lean and obese subjects. International Journal of Pancreatology, 3: 241-248.
Koopman, RJ, Swofford, SJ, Beard, MN & Meadows, SE 2009, Obesity and metabolic disease. Primary Care: Clinics in Office Practice, 36: 257-270.
Kumar, U & Singh, S 2020, Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity. International Journal of Molecular Sciences, 21: 2568.
Lelievre, V, Favrais, G, Abad, C, Adle Biassette, H, Lu, Y, Germano, PM & Waschek, JA 2007, Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease. Peptides, 28: 1688-1699.
Longnecker, DS, Gorelick, F & Thompson, ED 2018, Anatomy, histology, and fine structure of the pancreas. The Pancreas. Chichester, UK: John Wiley and Sons, Ltd, 10-23.
Longuet, C, Sinclair, EM, Maida, A, Baggio, LL, Maziarz, M, Charron, MJ & Drucker, DJ 2008, The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metabolism, 8: 359-371.
Lu, M, Lu, Q, Zhang, Y & Tian, G 2011, ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. Journal of Biomedical Research, 25: 266-273.
Madsbad, S 2014, The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications. Diabetes, Obesity and Metabolism, 16: 9-21.
Miyake, H, Sakagami, J, Yasuda, H, Sogame, Y, Kato, R, Suwa, K & Itoh, Y 2018, Association of fatty pancreas with pancreatic endocrine and exocrine function. PloS One, 13: e0209448.
Mousum, SA, Ahmed, S, Gawali, B, Kwatra, M, Ahmed, A & Lahkar, M 2018, Nyctanthes arbor-tristis leaf extract ameliorates hyperlipidemia-and hyperglycemia-associated nephrotoxicity by improving anti-oxidant and anti-inflammatory status in high-fat diet–streptozotocin-induced diabetic rats. Inflammopharmacology, 26: 1415-1428.
Nagulesparan, M, Savage, PJ, Unger, RH & Bennett, PH 1979, A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes, 28: 980-983.
Ni, K, Yang, JY, Baeg, K, Leiter, AC, Mhango, G, Gallagher, EJ & Kim, MK 2021, Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare analysis of 5235 patients. Cancer Reports, e1387.
Nöthlings, U, Wilkens, LR, Murphy, SP, Hankin, JH, Henderson, BE & Kolonel, LN 2007, Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes and Control, 18: 165-175.
Okamoto, H, Cavino, K, Na, E, Krumm, E, Kim, SY, Cheng, X & Gromada, J 2017, Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice. Proceedings of the National Academy of Sciences, 114: 2753-2758.
Ozougwu, JC, Obimba, KC, Belonwu, CD & Unakalamba, CB 2013, The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology, 4: 46-57.
Papachristou, GI, Papachristou, DJ, Avula, H, Slivka, A & Whitcomb, DC 2006, Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology, 6: 279-285.
Persson-Sjögren, S, Forsgren, S & Lindström, P 2006, Vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide: effects on insulin release in isolated mouse islets in relation to metabolic status and age. Neuropeptides, 40: 283-290.
Rai, U, Thrimawithana, TR, Valery, C & Young, SA 2015, Therapeutic uses of somatostatin and its analogues: current view and potential applications. Pharmacology and Therapeutics, 152: 98-110.
Rehfeld, JF 2016, CCK, gastrin and diabetes mellitus. Biomarkers in Medicine, 10: 1125-1127.
Saisho, Y 2016, Pancreas volume and fat deposition in diabetes and normal physiology: consideration of the interplay between endocrine and exocrine pancreas. The Review of Diabetic Studies: RDS, 13: 132.
Sanlioglu, AD, Karacay, B, Balci, MK, Griffith, TS & Sanlioglu, S 2012, Therapeutic potential of VIP vs PACAP in diabetes. Journal of Molecular Endocrinology, 49: R157-R167.
Schilling, RJ & Mitra, AK 1991, Degradation of insulin by trypsin and alpha-chymotrypsin. Pharmaceutical Research, 8: 721-727.
Schweiger, M, Romauch, M, Schreiber, R, Grabner, GF, Hütter, S, Kotzbeck, P & Zechner, R 2017, Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. Nature Communications, 8: 1-15.
Sharma, R, Kumari, M, Prakash, P, Gupta, S & Tiwari, S 2020, Phosphoenolpyruvate carboxykinase in urine exosomes reflect impairment in renal gluconeogenesis in early insulin resistance and diabetes. American Journal of Physiology-Renal Physiology, 318: F720-F731.
Shimada, M, Ishibashi, S, Gotoda, T, Kawamura, M, Yamamoto, K, Inaba, T & Yamada, N 1995, Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 15: 1688-1694.
Somvanshi, RK, Jhajj, A, Heer, M & Kumar, U 2018, Characterization of somatostatin receptors and associated signaling pathways in pancreas of R6/2 transgenic mice. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1864: 359-373.
Sorrentino, SA, Besler, C, Rohrer, L, Meyer, M, Heinrich, K, Bahlmann, FH & Landmesser, U 2010, Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation, 121: 110-122.
Starosel'tseva, LK, Kniazeva, AP, Belovalova, IM & Abduraimova, GR 1988, The role of gastrin in regulating insulin and glucagon secretion in patients with diabetes mellitus. Problemy Endokrinologii, 34: 20-25.
Stern, JH, Smith, GI, Chen, S, Unger, RH, Klein, S & Scherer, PE 2019, Obesity dysregulates fasting-induced changes in glucagon secretion. Journal of Endocrinology, 243: 149-160.
Suarez-Pinzon, WL, Power, RF, Yan, Y, Wasserfall, C, Atkinson, M & Rabinovitch, A 2008, Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes, 57: 3281-3288.
Surya, S, Horowitz, JF, Goldenberg, N, Sakharova, A, Harber, M, Cornford, AS & Barkan, AL 2009, The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects. The Journal of Clinical Endocrinology and Metabolism, 94: 2828-2834.
Taschler, U, Radner, FP, Heier, C, Schreiber, R, Schweiger, M & Zimmermann, R 2011, Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. Journal of Biological Chemistry, 286: 17467-17477.
Tu, J, Zhang, J, Ke, L, Yang, Y, Yang, Q, Lu, G & Li, J 2017, Endocrine and exocrine pancreatic insufficiency after acute pancreatitis: long-term follow-up study. BMC Gastroenterology, 17: 1-9.
Villela, NR, Kramer Aguiar, LG, Bottino, DA, Wiernsperger, N & Bouskela, E 2009, Metabolic disturbances linked to obesity: the role of impaired tissue perfusion. Arquivos Brasileiros de Endocrinologia and Metabologia, 53: 238-245.
Vu, JP, Larauche, M, Flores, M, Luong, L, Norris, J, Oh, S & Germano, PM 2015, Regulation of appetite, body composition, and metabolic hormones by vasoactive intestinal polypeptide (VIP). Journal of Molecular Neuroscience, 56: 377-387.
Wu, X, Conlin, VS, Morampudi, V, Ryz, NR, Nasser, Y, Bhinder, G & Jacobson, K 2015, Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. Plos One, 10: e0125225.
Yadav, R, Bhartiya, JP, Verma, SK & Nandkeoliar, MK 2013, The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions. Journal of Clinical and Diagnostic Research: JCDR, 7: 1291.
Yu, XX, Qiu, WL, Yang, L, Zhang, Y, He, MY, Li, LC & Xu, CR 2019, Defining multistep cell fate decision pathways during pancreatic development at single‐cell resolution. The Embo Journal, 38: e100164.
Zhao, J, Zhang, Y, Wei, F, Song, J, Cao, Z, Chen, C & Li, WD 2019, Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts. Journal of Translational Medicine, 17: 1-7.
)